Archive: The Common Good
Reducing the Strain by helping regional CF patients.
Dr George Tay and his team are working to develop and online educational hub for clinicians to locate the latest information on Cystic Fibrosis, CF treatments, and related ailments and…
How a cough led to world-class treatment for CF
Years ago Dr Scott Bell set out to answer a simple question: how far could bacteria in a cough travel? While this information might seem trivial for the general public,…
Improving the quality of life for Cystic Fibrosis patients
Tiffany is investigating the optimal antibiotic doses for adult CF patients so they can not only survive but thrive.
Using blood to help predict lung cancer progression
Professor Kwun Fong and his team are committed to find a way to non-invasively predict disease progression in lung cancer patients, by assessing their blood – using small vesicles known…
Professor Rayleen Bowman’s team hope to change this by developing a new method that will allow for highly personalised treatment based on the results of gained in early testing.
Personalised treatments for lung cancer
In the largest research project of its kind, looking at the lung cancer population in Australia, the UQ Thoracic lab are looking to identify and document 420 different types of…
Keeping lungs alive outside the body
Our team at The Prince Charles Hospital heard about technology that was being trialled in Europe, and decided to develop and test it in Australia. Put very simply, the idea…
Can stem cell therapy reduce lung rejection?
Dr Chambers is leading a nationwide study using stem cell therapy to treat lung transplant rejection and improve acceptance rates and transplant lung function in patients – vastly improving their…
Understanding lung rejection in transplant patients
Currently lung rejection is experienced by 50% of these patients within five years of their life-saving transplant. The Lung Transplant Research team want to improve the odds for these recipients.
Catching sepsis before it takes hold
Dr Hahn Pham hopes the use of a non-invasive skin probe will help identify patients at risk of organ dysfunction and deterioration more easily.
Why does cirrhosis affect the brain so dramatically?
Dr Tony Rahman is studying hepatic encephalopathy, a syndrome in patients with cirrhosis, in a bid to better understand its underlying causes and development.
Dr Eamonn Eeles and his team are replicating and developing a new isotope to use in the radiography of the brain that will allow areas of the brain, that haven't…